Literature DB >> 1525439

Evaluation of a screening instrument for dementia in ageing mentally retarded persons.

H M Evenhuis1.   

Abstract

The value of a standardized hetero-anamnestic questionnaire, the Dementia Questionnaire for Mentally Retarded Persons (DMR), as a screening instrument for diagnosis of early dementia, has been evaluated during a longitudinal follow-up of 139 institutionalized ageing mentally retarded subjects. By means of decision analysis, provisional criteria have been derived for a diagnosis, based on absolute DMR scores and on scorechanges through time. For different intellectual levels, separate criteria are required for interpretation of absolute scores, but longitudinal scorechanges might be independent of the intellectual level. The DMR was only evaluated for the mildly and moderately retarded intelligence categories, because of the small number of dementing persons among the severely and profoundly retarded subjects. Causes of false-positivity and false-negativity are considered.

Entities:  

Mesh:

Year:  1992        PMID: 1525439     DOI: 10.1111/j.1365-2788.1992.tb00532.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  21 in total

1.  Gait adaptations in response to perturbations in adults with Down syndrome.

Authors:  Beth A Smith; James A Ashton-Miller; Beverly D Ulrich
Journal:  Gait Posture       Date:  2010-05-07       Impact factor: 2.840

2.  Neuroimaging of individuals with Down's syndrome at-risk for dementia: evidence for possible compensatory events.

Authors:  R J Haier; K Head; E Head; I T Lott
Journal:  Neuroimage       Date:  2007-10-12       Impact factor: 6.556

3.  Alzheimer's Disease in Adults with Down Syndrome.

Authors:  Warren B Zigman; Darlynne A Devenny; Sharon J Krinsky-McHale; Edmund C Jenkins; Tiina K Urv; Jerzy Wegiel; Nicole Schupf; Wayne Silverman
Journal:  Int Rev Res Ment Retard       Date:  2008-01-01

4.  Positron emission tomography of brain β-amyloid and τ levels in adults with Down syndrome.

Authors:  Linda D Nelson; Prabha Siddarth; Vladimir Kepe; Kevin E Scheibel; S C Huang; Jorge R Barrio; Gary W Small
Journal:  Arch Neurol       Date:  2011-06

5.  Rapid assessment of cognitive function in down syndrome across intellectual level and dementia status.

Authors:  D M Walsh; E Doran; W Silverman; A Tournay; N Movsesyan; I T Lott
Journal:  J Intellect Disabil Res       Date:  2015-05-29

6.  Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation.

Authors:  Ira T Lott; Eric Doran; Vinh Q Nguyen; Anne Tournay; Elizabeth Head; Daniel L Gillen
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

7.  Down syndrome and dementia: seizures and cognitive decline.

Authors:  Ira T Lott; Eric Doran; Vinh Q Nguyen; Anne Tournay; Nina Movsesyan; Daniel L Gillen
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

8.  Plasma amyloid-β as a function of age, level of intellectual disability, and presence of dementia in Down syndrome.

Authors:  Elizabeth Head; Eric Doran; Mihaela Nistor; MaryAnn Hill; Frederick A Schmitt; Richard J Haier; Ira T Lott
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

9.  Cognitive Profiles on the Severe Impairment Battery Are Similar in Alzheimer Disease and Down Syndrome With Dementia.

Authors:  Malcolm B Dick; Eric Doran; Michael Phelan; Ira T Lott
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jul-Sep       Impact factor: 2.703

10.  Blood-based biomarkers for Down syndrome and Alzheimer's disease: A systematic review.

Authors:  Melissa E Petersen; Sid E O'Bryant
Journal:  Dev Neurobiol       Date:  2019-09-03       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.